New research findings presented at the 2019 ACR/ARP Annual Meeting found that annual spending on biologic DMARDS (biologics) by U.S. public programs and beneficiaries nearly doubled from 2012 to 2016. The study showed post-market ...
Nov 10, 2019
0
1
(HealthDay)—Its extremely high price tag means that a lifesaving medication to treat young children with spinal muscular atrophy is simply too expensive for most families.
Jul 30, 2019
0
1
Frustrated by the rising cost of prescription drugs, California health advocates hope sunlight and a dose of shame will discourage drugmakers from raising their prices too quickly or introducing new medications at prices ...
Jul 10, 2016
0
6
Merck filed a lawsuit Tuesday challenging a new White House-backed program to limit drug prices, calling the initiative an unconstitutional "extortion" that will harm pharmaceutical innovation.
Jun 6, 2023
0
1
Intermediaries are negotiating good drug prices but lack the incentives to pass savings to beneficiaries and taxpayers, study finds
Jul 7, 2021
0
2
US President Joe Biden on Tuesday called on pharmaceutical giants Novo Nordisk and Eli Lilly to lower prices for diabetes and weight loss drugs such as Ozempic, saying firms must stop "ripping off the American people."
Jul 2, 2024
0
0
Demand for prescription medications in the U.S. is at an all time high, given that 50% of adults have at least one chronic condition, and 25% have two or more. Sixty percent of the population, and 90% of Medicare beneficiaries ...
Sep 11, 2019
0
2
Although the Inflation Reduction Act of 2022 (IRA) aimed to increase patient access to prescription drugs and decrease spending, researchers warn that it may have unintended negative impacts on patients in the long run.
Apr 13, 2023
0
10
Most consumers haven't shopped around for standard medical procedures such as a knee replacement, but reference pricing could open that possibility for many services and lower health care costs at the same time.
Jul 15, 2019
0
2
Federal agencies that regulate drug pricing and healthcare insurance are concerned that an industry practice of using rebates to lower drug costs for insurers has led to increases in list prices and out-of-pockets costs for ...
Jun 15, 2021
0
4
